"Tumor Virus Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Infections produced by oncogenic viruses. The infections caused by DNA viruses are less numerous but more diverse than those caused by the RNA oncogenic viruses.
| Descriptor ID |
D014412
|
| MeSH Number(s) |
C02.928
|
| Concept/Terms |
Tumor Virus Infections- Tumor Virus Infections
- Infections, Tumor Virus
- Infection, Tumor Virus
- Tumor Virus Infection
|
Below are MeSH descriptors whose meaning is more general than "Tumor Virus Infections".
Below are MeSH descriptors whose meaning is more specific than "Tumor Virus Infections".
This graph shows the total number of publications written about "Tumor Virus Infections" by people in this website by year, and whether "Tumor Virus Infections" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 6 | 2 | 8 |
| 1995 | 3 | 1 | 4 |
| 1996 | 4 | 1 | 5 |
| 1997 | 4 | 1 | 5 |
| 1998 | 6 | 1 | 7 |
| 1999 | 5 | 1 | 6 |
| 2000 | 2 | 2 | 4 |
| 2001 | 1 | 1 | 2 |
| 2002 | 4 | 1 | 5 |
| 2003 | 3 | 2 | 5 |
| 2004 | 5 | 1 | 6 |
| 2005 | 6 | 1 | 7 |
| 2006 | 2 | 0 | 2 |
| 2007 | 3 | 0 | 3 |
| 2008 | 3 | 1 | 4 |
| 2009 | 2 | 2 | 4 |
| 2010 | 5 | 1 | 6 |
| 2011 | 1 | 1 | 2 |
| 2012 | 3 | 4 | 7 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 4 | 1 | 5 |
| 2017 | 0 | 1 | 1 |
| 2018 | 4 | 0 | 4 |
| 2019 | 1 | 1 | 2 |
| 2020 | 1 | 1 | 2 |
| 2021 | 1 | 0 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Tumor Virus Infections" by people in Profiles.
-
Posoleucel in Kidney Transplant Recipients with BK Viremia: Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. J Am Soc Nephrol. 2024 May 01; 35(5):618-629.
-
BK Virus Epidemiology, Risk Factors, and Clinical Outcomes: An Analysis of Hematopoietic Stem Cell Transplant Patients at Texas Children's Hospital. J Pediatric Infect Dis Soc. 2021 Apr 30; 10(4):492-501.
-
Development and validation of a risk assessment tool for BKPyV Replication in allogeneic stem cell transplant recipients. Transpl Infect Dis. 2020 Oct; 22(5):e13395.
-
The Cancer Microbiome: Distinguishing Direct and Indirect Effects Requires a Systemic View. Trends Cancer. 2020 03; 6(3):192-204.
-
Lymphocyte telomere length predicts clinical outcomes of HPV-positive oropharyngeal cancer patients after definitive radiotherapy. Carcinogenesis. 2019 07 06; 40(6):735-741.
-
Ciprofloxacin for BK viremia prophylaxis in kidney transplant recipients: Results of a prospective, double-blind, randomized, placebo-controlled trial. Am J Transplant. 2019 06; 19(6):1831-1837.
-
HIV-related Malignancies and Mimics: Imaging Findings and Management. Radiographics. 2018 Nov-Dec; 38(7):2051-2068.
-
Conversion from tacrolimus-mycophenolate mofetil to tacrolimus-mTOR immunosuppression after kidney-pancreas transplantation reduces the incidence of both BK and CMV viremia. Clin Transplant. 2018 06; 32(6):e13265.
-
De novo donor-specific antibody following BK nephropathy: The incidence and association with antibody-mediated rejection. Clin Transplant. 2018 03; 32(3):e13194.
-
The evolution of the epidemiological landscape of head and neck cancer in Italy: Is there evidence for an increase in the incidence of potentially HPV-related carcinomas? PLoS One. 2018; 13(2):e0192621.